You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
2026 › June › 19
Pharma
40 days ago
While the market's enthusiasm for one of Zealand's experimental drugs has cooled, investors are shifting focus to amylin-based medicines as a growth driver
page 1 of 1